CIK: 0001844002
Total reported value
$56.8M
Reporting period: 2024-12-31 · Number of holdings: 5
Alerce Investment Management, L.P. disclosed 5 holdings in its latest 13F filing for the period ending 2024-12-31, with total reported value of $56.8M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "A"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ANNX | Annexon INC | Stock-Other | 66.89% | — | — | |
| 2 | AKBA | Akebia Therapeutics INC | Stock-Other | 19.23% | — | — | |
| 3 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 7.19% | — | -57.26% | |
| 4 | AMWL | American Well Corp-class A | Stock-Other | 6.69% | — | — | |
| 5 | WHWK | Whitehawk Therapeutics INC | Stock-Other | — | — | — |
Performance for Q3 2026
+5.2%
Performance Last 4 Quarters
+34.5%
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2024-12-31 | 5 | $56.8M | 0 | |
| 2024-09-30 | 5 | $62.3M | 0 | |
| 2024-06-30 | 5 | $51.0M | 0 | |
| 2024-03-31 | 5 | $95.1M | 0 | |
| 2023-12-31 | 5 | $75.2M | 0 | |
| 2023-09-30 | 6 | $58.5M | 0 | |
| 2023-06-30 | 6 | $76.9M | 0 | |
| 2023-03-31 | 6 | $75.7M | 0 | |
| 2022-12-31 | 6 | $86.9M | 0 | |
| 2022-09-30 | 7 | $103.9M | 0 | |
| 2022-06-30 | 7 | $53.9M | 0 | |
| 2022-03-31 | 7 | $59.0M | 0 | |
| 2021-12-31 | 7 | $98.3M | 0 | |
| 2021-09-30 | 7 | $146.1M | 0 | |
| 2021-06-30 | 7 | $184.2M | 100 | |
| 2021-03-31 | 7 | $226.0M | 33 | |
| 2020-12-31 | 7 | $253.9M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-13 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-09 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-09 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-04 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-09 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-11 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-12 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-11 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001467112
Total reported value
$56.8M
270 stks
2013-06-30
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001513857
Total reported value
$56.8M
12 stks
2016-09-30
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001822973
Total reported value
$56.9M
14 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001397144
Total reported value
$306.9M
19 stks
2022-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Verona Pharma PLC - Adr
CIK 0001542952
Total reported value
$33.0M
16 stks
2025-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Verona Pharma PLC - Adr
CIK 0001582844
Total reported value
$141.8M
27 stks
2026-03-31
1 of the top 5 holdings overlap, including Whitehawk Therapeutics INC